Grifols, S.A

(PINK:GIFLF)

Latest On Grifols, S.A (GIFLF):

Date/Time Type Description Signal Details
2021-06-03 06:11 ESTDividendA dividend of $0.36 has been announced on May 21, 2021. It will be paid Jun 7, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-03-02 13:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 22:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 13:28 ESTFinancialsCompany financials have been released.Neutral
2020-10-26 05:57 ESTDividendA dividend of $0.16 has been announced on N/A. It will be paid Oct 28, 2020 with an ex-dividend date of Oct 26, 2020.Neutral
2020-09-26 14:59 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:00 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 14:36 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:21 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 10:40 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:45 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 22:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:23 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:34 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:19 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:27 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:32 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:09 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:43 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:22 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:21 ESTFinancialsCompany financials have been released.Neutral
2020-04-23 18:06 ESTFinancialsCompany financials have been released.Neutral
2020-04-22 14:00 ESTFinancialsCompany financials have been released.Neutral
2020-04-20 06:09 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 10:09 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 02:21 ESTStock SplitA stock split has occured on Jan 4, 2016 with a split factor of 2:1.Neutral
2020-04-03 22:44 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 22:15 ESTFinancialsCompany financials have been released.Neutral
2020-03-06 20:48 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:49 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 23:53 ESTFinancialsCompany financials have been released.Neutral
2020-02-22 01:26 ESTFinancialsCompany financials have been released.Neutral
2020-02-21 00:55 ESTFinancialsCompany financials have been released.Neutral
2020-02-18 01:12 ESTFinancialsCompany financials have been released.Neutral
2020-02-13 01:26 ESTFinancialsCompany financials have been released.Neutral
2020-02-10 11:30 ESTStock SplitA stock split has occured on Jan 4, 2016 with a split factor of 2:1.Neutral

About Grifols, S.A (GIFLF):

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GIFLF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 23,655
  • Last Split Factor2:1
  • Last Split Date2016-01-04
  • Fiscal Year EndDecember
  • Web URLhttp://www.grifols.com
View More

Valuation

  • Trailing PE 21.52
  • Forward PE 18.35
  • Price/Sales (Trailing 12 Mt.) 2.65
  • Price/Book (Most Recent Quarter) 2.76
  • Enterprise Value Revenue 4.17
  • Enterprise Value EBITDA 15.63
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 12%
  • Return on Assets 5%
  • Return on Equity 10%
  • Earnings Per Share $1.20
  • Revenue Per Share $0
  • Gross Profit 2.51 billion
  • Quarterly Earnings Growth -3.8%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 31.07
  • Environment Score 7.04
  • Social Score 25.71
  • Governance Score 15.83
  • Controversy Level 2
View More

Highlights

  • Market Capitalization 15.28 billion
  • PE Ratio 7.7
  • PEG Ratio 2.72
  • Book Value Per Share $7.12
View More

Share Statistics

  • Shares Outstanding 426.13 million
  • Shares Float 428.34 million
  • % Held by Insiders 3107%
  • % Held by Institutions 38.34%
View More

Technicals

  • Beta 0.05
  • 52 Week High $35.71
  • 52 Week Low $22.8
  • 50 Day Moving Average 27.03
  • 200 Day Moving Average 28.46
View More

Dividends

  • Forward Annual Dividend Rate $0.41
  • Forward Annual Dividend Yield 1.6%
  • Payout Ratio 26%
  • Dividend Date N/A
  • ExDividend Date 2020-10-26
  • Dividend Per Share $0.47
  • Dividend Yield 0%
View More

Grifols, S.A (GIFLF) Dividend Calendar:

Grifols, S.A pays out 26% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Grifols, S.A (GIFLF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-12-31$1.35 billion$0.23$0.26-10.42%
2020-06-302020-09-30$N/A$0.46$0.2862.75%
2020-03-312020-06-30$N/A$0.06$0.26-78.38%
2019-12-312020-03-31$1.36 billion$0.30$0.30-0.8%
2019-09-302019-12-31$1.31 billion$0.32$0.2719.93%
2019-06-302019-09-30$1.27 billion$0.22$0.28-22.14%
2019-03-312019-06-30$1.16 billion$0.28$0.2323.61%
2018-12-312019-03-31$1.22 billion$0.19$0.26-26.65%
2018-09-302018-12-31$1.32 billion$0.21$0.27-23.11%
2018-06-302018-09-30$801.28 million$0.26$0.26-1.77%
2018-03-312018-06-30$779.32 million$0.30$0.2238%
2017-12-312018-03-31$1.07 billion$0.26$0.247.79%
2017-09-302017-12-31$1.06 billion$0.41$0.2469.58%
2017-06-302017-09-30$1.13 billion$0.26$0.26-0.15%
2017-03-312017-06-30$1.06 billion$0.24$0.24-0.04%
2016-12-312017-03-31$1.1 billion$0.21$0.22-3%
2016-09-302016-12-31$0.22$0.23-4.52%
2016-06-302016-09-30$0.24$0.227.23%
2016-03-312016-06-30$0.22$0.2011.05%
2015-12-312016-03-31$0.21$0.26-21.15%
2015-09-302015-12-31$0.20$0.22-6.91%
2015-06-302015-09-30$0.22$0.216.29%
2015-03-312015-06-30$0.21$0.210.76%
2014-12-312015-03-31$0.20$0.21-2.81%
2014-09-302014-12-31$0.23$0.2110.14%
2014-06-302014-09-30$0.21
2014-03-312014-06-30$0.21
2013-12-312014-03-31$0.24
2013-09-302013-12-31$0.15
2013-06-302013-09-30$0.17
2013-03-312013-06-30$0.18
2012-12-312013-03-31$0.17
2012-09-302012-12-31$0.11
2012-06-302012-09-30$0.12
2012-03-312012-06-30$0.12
2011-12-312012-03-31$0.13
2011-09-302011-12-31$0.01
2011-06-302011-09-30$0.05
2011-03-312011-06-30-$0.04$0.00
2010-12-312011-03-31$0.11$0.00
2010-09-302010-12-31$0.06$0.00

Grifols, S.A (GIFLF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GIFLF) Chart:

Grifols, S.A (GIFLF) News:

Below you will find a list of latest news for Grifols, S.A (GIFLF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GIFLF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Grifols, S.A (GIFLF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link